FDA: Pfizer, AstraZeneca, Sinovac, Sputnik apply for EUA for booster shot | Inquirer News
Close  

FDA: Pfizer, AstraZeneca, Sinovac, Sputnik apply for EUA for booster shot

By: - Reporter / @DYGalvezINQ
/ 12:54 PM November 03, 2021
Four vaccine makers have so far sent applications to the FDA for an emergency use approval for booster shots, the agency said Wednesday. 

Food and Drug Administration director general and DOH Usec. Eric Domingo. Screengrab from Department of Health (Philippines) Facebook Live

MANILA, Philippines — Four vaccine makers have so far sent applications to the Food and Drug Administration (FDA) for an emergency use approval for their third dose or booster shot, the agency said Wednesday.

In a taped briefing with President Rodrigo Duterte aired on Wednesday morning, FDA Director-General Eric Domingo said the drug firms for COVID-19 vaccines Pfizer, AstraZeneca, Sinovac, and Sputnik V have applied for “product variation” or amendment of their emergency use approval.

ADVERTISEMENT

“Nag-request sila na ma-include ang third dose sa kanilang regimen or a booster dose,” he said.

(They have requested to include a third dose or booster dose in their regimen.)

FEATURED STORIES

“Pinadala nila ‘yung kanilang scientific data available at ito ‘yung inaaral ngayon ng ating mga expert,” he added.

(They have sent their scientific data available and our experts are studying them now.)

The Department of Health (DOH) earlier explained that a COVID-19 third dose and booster shot are different.

Citing the World Health Organization, the DOH said booster shots are provided due to waning immunity several months after the primary course of vaccination.

Meanwhile, third doses are given to people such as individuals with comorbidity and senior citizens who may have not mounted sufficient immunity against the disease.

The FDA is also studying mixing and matching different vaccine brands for the third dose or booster shot, Domingo said.

“Applications for booster shots are now under evaluation and our vaccine experts are reviewing submitted data,” Domingo said.

ADVERTISEMENT

With this, he said that the “trend” seen for booster or third doses is that it will be not for the general population but only for selected people who would need it, particularly the elderly, immunocompromised, and healthcare workers.

Authorities are also waiting for the final recommendation of the World Health Organization (WHO) on booster shots, which are expected to be released within two weeks, Domingo said.

He added that the Department of Health (DOH) is already preparing the guidelines for the rollout of third doses.

However, while the country is waiting for the final recommendations on booster doses, Domingo said the FDA is urging local government units to still give priority vaccination to those who have not yet received a single dose.

“Priority pa rin natin bakunahan muna lahat ng unvaccinated,” he said.

The administration of booster shots is eyed this month.

JPV

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link .

Read Next
Don't miss out on the latest news and information.

Subscribe to INQUIRER PLUS to get access to The Philippine Daily Inquirer & other 70+ titles, share up to 5 gadgets, listen to the news, download as early as 4am & share articles on social media. Call 896 6000.

TAGS: Booster Shot, COVID-19, FDA, third dose
For feedback, complaints, or inquiries, contact us.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and
acknowledge that I have read the Privacy Policy.



© Copyright 1997-2022 INQUIRER.net | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.